Literature DB >> 19329189

Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.

Yong Fang1, Qing-Long Shang, Jian-Yu Liu, Di Li, Wei-Zhen Xu, Xu Teng, Hong-Wei Zhao, Li-Juan Fu, Feng-Min Zhang, Hong-Xi Gu.   

Abstract

OBJECTIVE: To investigate the prevalence of occult hepatitis B virus (HBV) infection among hepatopathy patients and healthy people in China.
METHODS: The HBV DNA in 653 sera samples collected from cryptogenic chronic liver disease patients (159), hepatitis B surface antigen (HBsAg) negative hepatocellular carcinoma (HCC) patients (135) and HBsAg-negative healthy people (359) were tested by nested PCR using specific primers of the X region of the HBV genome. We performed real-time PCR to determine the levels of serum HBV-DNA.
RESULTS: Prevalence of occult HBV infection was 28.3% (45/159), 70.4% (95/135) and 10.6% (38/359) in cryptogenic chronic liver disease patients, HBsAg-negative HCC patients and HBsAg-negative healthy people, respectively. The prevalence of occult HBV infection in IgG anti-HBc-positive subjects was 100% (45/45), 86.7% (85/98) and 33.3% (14/42) in cryptogenic chronic liver disease patients, HBsAg-negative HCC patients and HBsAg-negative healthy people, respectively. In all cases, viral loads were low (<10(4)viral copies/mL).
CONCLUSION: The prevalence of occult HBV infection was significantly high among hepatopathy patients and healthy people in China. Thus, more meticulous attention should be given to prevent HBV transmission by blood transfusion or organ transplantation in endemic areas, and further studies on clinical implication and mechanism of occult HBV infection are required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329189     DOI: 10.1016/j.jinf.2009.02.013

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  35 in total

Review 1.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

2.  Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.

Authors:  Shan-Shan Wu; Quan-Yuan Shan; Wen-Xuan Xie; Bin Chen; Yang Huang; Yu Guo; Xiao-Yan Xie; Ming-De Lu; Bao-Gang Peng; Ming Kuang; Shun-Li Shen; Wei Wang
Journal:  Clin Transl Oncol       Date:  2019-06-06       Impact factor: 3.405

3.  A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population.

Authors:  Li-Zhang Chen; Wen-Qi Zhou; Shu-Shan Zhao; Zhi-Yu Liu; Shi-Wu Wen
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

4.  MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells.

Authors:  Qingliang Meng; Xiaoqi He; Guangwei Xie; Qingzhong Tian; Xiaogang Shu; Jin Li; Yong Xiao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

5.  Prevalence of occult hepatitis B virus infection in kidney transplant recipients.

Authors:  Cibele Franz; Renata de Mello Perez; Mariano Gustavo Zalis; Ana Carolina Jonard Zalona; Pedro Túlio Monteiro de Castro e Abreu Rocha; Renato Torres Gonçalves; Letícia Cancella Nabuco; Cristiane Alves Villela-Nogueira
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-08       Impact factor: 2.743

6.  Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption.

Authors:  S Bagaglio; G Bianchi; A Danise; L Porrino; C Uberti-Foppa; A Lazzarin; A Castagna; G Morsica
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

7.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

8.  Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

Authors:  Quan Yuan; Shan-Hai Ou; Chang-Rong Chen; Sheng-Xiang Ge; Bin Pei; Qing-Rui Chen; Qiang Yan; Yong-Cai Lin; Hong-Ying Ni; Cheng-Hao Huang; Anthony E T Yeo; James W K Shih; Jun Zhang; Ning-Shao Xia
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

Review 9.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

10.  Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.

Authors:  Deepu David; Anantharam Raghavendran; Ashish Goel; C Bharath Kumar; Thomas Alex Kodiatte; Deepak Burad; Priya Abraham; Banumathi Ramakrishna; Philip Joseph; Jeyamani Ramachandran; C E Eapen
Journal:  Indian J Gastroenterol       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.